According to a new report by Grand View Research, the global interventional cardiology device market is expected to reach USD 26.06 billion by 2020. Increasing prevalence of cardiovascular diseases coupled with adoption of minimally invasive surgeries is expected to boost the interventional cardiology device market over the forecast period.
Unhealthy lifestyle habits such as high alcohol consumption, smoking, and lack of physical exercise are triggering incidences of cardiovascular diseases. Furthermore, the number of congenital heart disease patients is on a constant rise and this acts as a growth driver for the market.
Request to Sample of This Report @ http://www.grandviewresearch.com/industry-analysis/interventional-cardiology-devices-market-analysis
According to a report published by the U.S. CDC (Centers for Disease Control and Prevention) in 2011, congenital heart defects are the most common birth defects in the U.S., affecting approximately 1% of the births every year. The treatment of cardiovascular disorders has changed dramatically due to the introduction of new drug therapies and devices such as guidewires and stents allowing the patient to live better quality and longer lives.
The advent of technologically advanced internal substitutes plays an integral role in this market and manufacturers focus on developing new products to curb problems associated with previous versions. For example, the evolution of stents began from bare metal stents and has now reached a completely new horizon in the form of disappearing stents (bio-absorbable stents). Stents accounted for over 70% market share primarily owing to high usage rates in 2013. Drug eluting and bio-absorbable stent are the major boosters of this product especially in Asia Pacific region.
Catheters in sync with stent are expected to register steady growth to reach up to a market size of over USD 2,000.0 million in 2020. The growth is primarily driven by primarily the rising demand for minimally invasive medical procedures in the field of cardiovascular diseases. Faster patient recovery time and lesser procedure duration are two most significant factors contributing towards the rising demand of these medical procedures.
The North America interventional cardiology device market in 2013 was valued at over USD 5.0 billion, owing to the factors such as favorable government initiatives pertaining to new product development, sophisticated healthcare infrastructure and increasing patient awareness levels coupled with relatively higher healthcare expenditures in the region.
On the other hand, the Asia Pacific market is expected to reach over USD 6.0 billion, growing at a lucrative rate over the forecast period. The growth is attributed to the presence of large untapped opportunities, rising healthcare expenditure, cardiovascular disease incidence rate, and disposable income levels. Prominent players operating in this industry includes Cordis Corporation, Abbott Laboratories, Medtronic, Inc, Terumo Medical Corporation, B. Braun Melsungen AG, and Boston Scientific.
Grand View Research has segmented the global interventional cardiology devices market on the basis of product, application and region:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
For More Information, Visit Grand View Research
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
Toll Free: 1-888-202-9519
Blog Site: http://www.grandviewresearchinc.blogspot.in/